Moolec Science S.A. (MLEC)

LU — Healthcare Sector
Peers: BAER  CDIO  CLABF  EUDA  GNLX  OCEA  ZIVO  ZVSA 

Automate Your Wheel Strategy on MLEC

With Tiblio's Option Bot, you can configure your own wheel strategy including MLEC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MLEC
  • Rev/Share 0.201
  • Book/Share 0.0718
  • PB 70.0762
  • Debt/Equity 7.8974
  • CurrentRatio 1.478
  • ROIC -0.3196

 

  • MktCap 20183775.0
  • FreeCF/Share -0.157
  • PFCF -3.2996
  • PE -23.6667
  • Debt/Assets 0.7038
  • DivYield 0
  • ROE -1.5093

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
BIOX, MLEC
Published: April 21, 2025 by: Accesswire
Sentiment: Neutral

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together …

Read More
image for news Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
BIOX, MLEC
Published: April 21, 2025 by: Accesswire
Sentiment: Neutral

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together …

Read More
image for news Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

About Moolec Science S.A. (MLEC)

  • IPO Date 2021-03-02
  • Website https://moolecscience.com
  • Industry Biotechnology
  • CEO Henk Hoogenkamp
  • Employees 52
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.